Company Profile: Beijing tricision Biotherapeu

About Us

Science and Technology

Research

About Us

tricision Therapeutics Inc.was founded in 2015 by scientists and physicians to translate fundamental research into real-world therapy. We are a biotechnology company dedicated to innovation and development of mRNA based therapies. With "Using nucleic acid...

SCIENCE AND TECHNOLOGY

Research

A highly efficient needle-free-injection delivery system for mRNA-LNP vaccination against SARS-CoV-2

Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12.

Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study

Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.

一 ABOUT US

一 SCIENCE AND TECHNOLOGY

一 Research

一 Contact us

WeChat Official Account